MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
MYGN on Nasdaq
Shares outstanding
93,104,451
Price per share
$6.15
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
88,546,250
Holdings value
$640,111,586
% of all portfolios
0%
Share change
-120,324
Value change
+$7,175,911
Average buys %
+0%
Average sells %
-0%
Number of holders
214
Price from insider filings
$6.15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $74,900,419 14,105,009 BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 8.5% -16% $56,990,583 -$9,941,091 7,882,515 -15% The Vanguard Group 30 Sep 2025
INTEGRATED CORE STRATEGIES (US) LLC 5.1% -4% $34,330,404 -$1,275,278 4,748,327 -3.6% Millennium Management LLC 30 Sep 2025
BARCLAYS PLC 4.2% -22% $28,480,691 -$6,945,955 3,939,238 -20% Barclays PLC 30 Sep 2025
Camber Capital Management LP 3.4% $22,320,000 3,100,000 Camber Capital Management LP 31 Dec 2024
DISCIPLINED GROWTH INVESTORS INC /MN 0.8% -86% $4,244,772 -$19,924,683 753,956 -82% DISCIPLINED GROWTH INVESTORS INC /MN 30 Jun 2025
As of 30 Sep 2025, MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 214 institutional shareholders filing 13F forms. They hold 88,546,250 shares of 93,104,451 outstanding shares (95%) .

Top 25 institutional shareholders own 75% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 14,879,427 -1.3% 0% $107,578,257
VANGUARD GROUP INC 8.5% 7,882,515 -15% 0% $56,990,583
STATE STREET CORP 5.3% 4,976,492 +3.5% 0% $35,980,037
MILLENNIUM MANAGEMENT LLC 5.1% 4,748,327 -3.6% 0.03% $34,330,404
GLENVIEW CAPITAL MANAGEMENT, LLC 4.9% 4,587,407 0% 0.81% $33,166,953
D. E. Shaw & Co., Inc. 4.9% 4,559,136 +1.1% 0.03% $32,962,553
MORGAN STANLEY 3.9% 3,616,925 -21% 0% $26,150,371
JACOBS LEVY EQUITY MANAGEMENT, INC 2.6% 2,442,912 +157% 0.07% $17,662,254
GEODE CAPITAL MANAGEMENT, LLC 2.4% 2,225,169 +0.1% 0% $16,090,499
GOLDMAN SACHS GROUP INC 2.3% 2,151,779 +68% 0% $15,557,363
DIMENSIONAL FUND ADVISORS LP 1.8% 1,695,896 -18% 0% $12,261,265
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.8% 1,678,900 +26% 0% $12,138,447
AQR CAPITAL MANAGEMENT LLC 1.7% 1,596,826 +51% 0.01% $11,545,052
Assenagon Asset Management S.A. 1.4% 1,304,163 +301% 0.01% $9,429,098
Fisher Asset Management, LLC 1.4% 1,278,927 -1.2% 0% $9,246,641
Connor, Clark & Lunn Investment Management Ltd. 1.4% 1,276,738 -8% 0.03% $9,230,816
Qube Research & Technologies Ltd 1.3% 1,186,507 -42% 0.01% $8,578,446
NORTHERN TRUST CORP 1.2% 1,135,565 +18% 0% $8,210,134
FEDERATED HERMES, INC. 1.2% 1,129,538 +0.64% 0.01% $8,166,560
Point72 Asset Management, L.P. 1.2% 1,073,963 +100% 0.02% $7,764,751
ALGERT GLOBAL LLC 0.98% 913,065 0.11% $6,601,000
ACADIAN ASSET MANAGEMENT LLC 0.87% 810,512 -16% 0.01% $5,856,000
HRT FINANCIAL LP 0.85% 790,569 +465% 0.02% $5,715,000
TWO SIGMA INVESTMENTS, LP 0.78% 728,674 +34% 0.01% $5,268,313
Nuveen, LLC 0.78% 724,896 -1.9% 0% $5,240,999

Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 1,617,330 $9,954,909 -$1,023,488 $6.15 8
2025 Q3 88,546,250 $640,111,586 +$7,175,911 $7.23 214
2025 Q2 90,529,530 $480,755,771 -$73,903,588 $5.31 216
2025 Q1 93,969,029 $833,362,943 +$10,158,296 $8.87 226
2024 Q4 92,375,178 $1,266,992,283 -$38,609,730 $13.71 215
2024 Q3 90,691,605 $2,483,201,789 -$46,730,979 $27.39 242
2024 Q2 92,267,243 $2,256,709,187 -$39,028,941 $24.46 222
2024 Q1 93,842,572 $2,001,184,496 +$85,643,654 $21.32 185
2023 Q4 89,898,458 $1,720,778,542 +$139,092,939 $19.14 193
2023 Q3 82,696,930 $1,326,499,466 +$18,782,858 $16.04 184
2023 Q2 81,069,882 $1,879,159,822 -$25,379,016 $23.18 184
2023 Q1 82,216,167 $1,909,846,418 +$45,174,636 $23.23 186
2022 Q4 80,553,035 $1,168,812,560 -$19,067,888 $14.51 191
2022 Q3 81,539,353 $1,555,961,809 +$26,155,420 $19.08 184
2022 Q2 79,888,231 $1,451,741,809 +$19,085,207 $18.17 185
2022 Q1 78,868,034 $1,987,215,536 +$13,382,979 $25.20 198
2021 Q4 78,283,503 $2,159,672,726 -$41,784,396 $27.60 191
2021 Q3 79,271,409 $2,560,639,030 +$122,124,573 $32.29 208
2021 Q2 75,479,842 $2,308,615,173 +$49,345,949 $30.58 198
2021 Q1 73,860,328 $2,248,603,947 -$35,142,715 $30.45 193
2020 Q4 74,996,999 $1,483,013,849 +$38,048,718 $19.78 176
2020 Q3 78,424,909 $1,022,586,628 +$19,999,510 $13.04 185
2020 Q2 72,886,989 $826,507,154 -$36,910,370 $11.34 188
2020 Q1 73,615,521 $1,053,548,995 -$123,804,400 $14.31 182
2019 Q4 78,975,742 $2,150,434,501 +$34,090,453 $27.23 219
2019 Q3 77,664,088 $2,224,059,833 +$28,066,291 $28.63 218
2019 Q2 77,043,291 $2,139,470,240 -$65,887,514 $27.78 231
2019 Q1 78,750,518 $2,615,130,134 +$97,424,616 $33.20 258
2018 Q4 76,435,291 $2,221,293,320 +$6,245,068 $29.07 259
2018 Q3 75,541,156 $3,474,992,493 +$111,969,670 $46.00 278
2018 Q2 73,460,919 $2,745,652,207 -$56,197,259 $37.37 249
2018 Q1 75,270,680 $2,223,643,624 +$16,205,290 $29.55 253
2017 Q4 74,845,228 $2,570,635,302 -$22,877,461 $34.34 245
2017 Q3 75,226,201 $2,721,461,140 -$231,871,181 $36.18 216
2017 Q2 82,113,528 $2,121,588,355 -$24,472,655 $25.84 236
2017 Q1 83,778,198 $1,608,413,977 +$174,303,798 $19.20 231
2016 Q4 79,796,561 $1,330,583,231 -$62,889,463 $16.67 217
2016 Q3 82,688,844 $1,701,064,840 -$42,443,387 $20.58 217
2016 Q2 81,092,174 $2,481,784,291 -$33,967,136 $30.60 250
2016 Q1 81,837,318 $3,063,093,588 -$304,511,458 $37.43 230
2015 Q4 89,677,551 $3,871,037,353 -$60,385,179 $43.16 229
2015 Q3 91,172,269 $3,416,315,178 -$59,259,619 $37.48 231
2015 Q2 92,876,142 $3,156,788,683 -$19,072,131 $33.99 229
2015 Q1 92,602,268 $3,277,634,496 -$49,667,719 $35.40 247
2014 Q4 94,137,654 $3,207,918,704 -$81,570,182 $34.06 265
2014 Q3 95,844,578 $3,696,576,481 -$222,241,326 $38.57 270
2014 Q2 102,126,793 $3,952,163,523 -$223,082,374 $38.92 282
2014 Q1 108,172,480 $3,703,941,847 +$239,360,362 $34.19 277